These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4355201)

  • 21. Mode of action of N6-O2'-dibutyryl cyclic 3',5' AMP on fat cell metabolism.
    Jarett L; Smith RM
    Diabetes; 1974 Jan; 23(1):29-40. PubMed ID: 4358604
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of insulin on the lipolytic system of rat fat cells.
    Schönhöfer PS; Skidmore IF; Krishna G
    Horm Metab Res; 1972 Nov; 4(6):447-54. PubMed ID: 4347822
    [No Abstract]   [Full Text] [Related]  

  • 23. Controle of the metabolism and lipolytic effects of cyclic 3',5'-adenosine monophosphate in adipose tissue by insulin, methyl xanthines, and nicotinic acid.
    Blecher M; Merlino NS; Ro'Ane JT
    J Biol Chem; 1968 Jul; 243(14):3973-7. PubMed ID: 4298515
    [No Abstract]   [Full Text] [Related]  

  • 24. Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells.
    Lovell-Smith CJ; Manganiello VC; Vaughan M
    Biochim Biophys Acta; 1977 Apr; 497(2):447-58. PubMed ID: 192314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anti-insulin receptor antibodies on insulin-sensitive phosphodiesterase in rat fat cells.
    Suzuki T; Makino H; Kanatsuka A; Yoshida S
    Horm Metab Res; 1988 May; 20(5):257-60. PubMed ID: 2841215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms regulating adipose-tissue pyruvate dehydrogenase.
    Martin BR; Denton RM; Pask HT; Randle PJ
    Biochem J; 1972 Sep; 129(3):763-73. PubMed ID: 4658997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase activity of rat and human adipose tissue.
    Solomon SS
    J Lab Clin Med; 1972 Apr; 79(4):598-610. PubMed ID: 4336560
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possible unmasking of noradrenaline receptors by linoleic acid-rich phospholipids in fat cell membranes. II. Adenylate cyclase and phosphodiesterase activities].
    Counis R
    Biochim Biophys Acta; 1973 Jun; 306(3):391-5. PubMed ID: 4353704
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation, by insulin, of lipoprotein lipase and phosphodiesterase activities in rat adipose tissue.
    Desai K; Hollenberg CH
    Isr J Med Sci; 1975 Jun; 11(6):540-50. PubMed ID: 169209
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclic nucleotide phosphodiesterases and thyroid hormones.
    Van Inwegen RG; Robison GA; Thompson WJ
    J Biol Chem; 1975 Apr; 250(7):2452-6. PubMed ID: 164441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V; Degerman E; Elks M
    Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
    [No Abstract]   [Full Text] [Related]  

  • 32. An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats.
    Das I; Chain EB
    Biochem J; 1972 Jul; 128(3):95P-96P. PubMed ID: 4344014
    [No Abstract]   [Full Text] [Related]  

  • 33. Antilipolytic action of insulin on fat cells.
    Fain JN; Rosenberg L
    Diabetes; 1972; 21(2 Suppl):414-25. PubMed ID: 4340997
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells.
    Allen DO; Clark JF; Ashmore J
    J Pharmacol Exp Ther; 1973 May; 185(2):379-85. PubMed ID: 4350040
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver.
    A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES
    Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents.
    Makino H; de Buschiazzo PM; Pointer RH; Jordan JE; Kono T
    J Biol Chem; 1980 Aug; 255(16):7845-9. PubMed ID: 6249817
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline.
    Schönhöfer PS; Skidmore IF; Bourne HR; Krishna G
    Pharmacology; 1972; 7(2):65-77. PubMed ID: 4340944
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of the effect of nicotinic acid on cyclic nucleotide phosphodiesterase activity in rat heart and adipose tissue.
    Therriault DG; Winters VG
    Life Sci I; 1970 Apr; 9(8):421-8. PubMed ID: 4323330
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver low-Km, hormone-sensitive phosphodiesterase.
    Loten EG
    Methods Enzymol; 1988; 159():736-44. PubMed ID: 2842635
    [No Abstract]   [Full Text] [Related]  

  • 40. Soluble and membrane-bound cyclic AMP diesterase activity with a low Michaelis constant in baker's yeast.
    Londesborough JC
    FEBS Lett; 1975 Feb; 50(2):283-7. PubMed ID: 163211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.